IN2013CH04473A - - Google Patents

Info

Publication number
IN2013CH04473A
IN2013CH04473A IN4473CH2013A IN2013CH04473A IN 2013CH04473 A IN2013CH04473 A IN 2013CH04473A IN 4473CH2013 A IN4473CH2013 A IN 4473CH2013A IN 2013CH04473 A IN2013CH04473 A IN 2013CH04473A
Authority
IN
India
Prior art keywords
pharmaceutically acceptable
acceptable excipients
active layer
layer
telmisartan
Prior art date
Application number
Inventor
Eswara Gopala Krishna Murthy Dr Talasila
Ravi Sankar Kothamasu
Original Assignee
Eswara Gopala Krishna Murthy Dr Talasila
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eswara Gopala Krishna Murthy Dr Talasila filed Critical Eswara Gopala Krishna Murthy Dr Talasila
Priority to IN4473CH2013 priority Critical patent/IN2013CH04473A/en
Publication of IN2013CH04473A publication Critical patent/IN2013CH04473A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A capsule composition comprising: (a) an inert core comprising sugar sphere, (b) an active layer comprising telmisartan, sodium hydroxide, tween 80 and one or more pharmaceutically acceptable excipients, (c) an overcoating layer comprising one or more pharmaceutically acceptable excipients over the active layer.
IN4473CH2013 2013-10-01 2013-10-01 IN2013CH04473A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN4473CH2013 IN2013CH04473A (en) 2013-10-01 2013-10-01

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN4473CH2013 IN2013CH04473A (en) 2013-10-01 2013-10-01

Publications (1)

Publication Number Publication Date
IN2013CH04473A true IN2013CH04473A (en) 2015-04-10

Family

ID=54398311

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4473CH2013 IN2013CH04473A (en) 2013-10-01 2013-10-01

Country Status (1)

Country Link
IN (1) IN2013CH04473A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117257769A (en) * 2023-10-11 2023-12-22 珠海润都制药股份有限公司 Telmisartan pellets and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117257769A (en) * 2023-10-11 2023-12-22 珠海润都制药股份有限公司 Telmisartan pellets and preparation method thereof

Similar Documents

Publication Publication Date Title
IL271420A (en) Methods for cell encapsulation, cell capsules and their use
EP4249055A3 (en) Tofacitinib oral sustained release dosage forms
MX2016001424A (en) Sweetener compositions.
PH12015502755A1 (en) Insulin glargine / lixisenatide fixed ratio formulation
PH12017501084A1 (en) Insulin glargine/lixisenatide fixed ratio formulation
MX367210B (en) Stable oral solutions for combined api.
MY176793A (en) Pharmaceutical tablet comprising acetylsalicylic acid and clopidogrel
EA201201202A1 (en) ORAL PHARMACEUTICAL COMPOSITION CONTAINING DABIGATRANE EXTILE
WO2014114255A3 (en) Positioning, quick-release bioadhesion agent and use
EA201400737A1 (en) DELIVERY SYSTEM ON THE BASIS OF A PELLET SET WITH IMMEDIATE release of an ACTIVE SUBSTANCE
AU2018300075A1 (en) Dual release dosage form capsule and methods, devices and systems for making same
PH12015500165A1 (en) Formulations and methods of manufacturing formulations for use in colonic evacuation
MX2019004554A (en) Pharmaceutical soft gelatin capsule dosage form with modified guar gum.
EA201891886A1 (en) CONTAINING PREGABALIN A THREE-LAYER TABLET WITH SLOW-RELEASE EXTRACTION FOR ORAL RECEPTION
GB2543709A (en) Pharmaceutical agent
IN2013CH04473A (en)
FR3021814B1 (en) CONNECTOR FOR THE MATRIX CONNECTION BETWEEN A HOUSING AND A SUPPORT COMPRISING A MAIN BODY
WO2016108507A3 (en) Composite tablet for oral administration comprising melatonin and sertraline
EP3065737A4 (en) Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form
WO2015108499A3 (en) Therapeutic implantable device
张树勇 First Female Amputee Climbing Mount Everest
王娟 The Contrastive Multimodal Study between Chinese and Western Movie Posters
WO2013144976A3 (en) Chewable soft gelatin capsule dosage form of mucolytic agents
EA201891885A1 (en) CONTAINING PREGABALINE HIGH-PUMPABLE THREE-LAYER TABLET WITH SLOW-DELIVERY FOR ORAL RECEPTION
顾曰国 A Whole Person